Back to Results
First PageMeta Content
Psychiatry / Tricyclic antidepressants / Organofluorides / Amines / Organochlorides / Antidepressant / Paroxetine / Venlafaxine / Sertraline / Chemistry / Organic chemistry / Selective serotonin reuptake inhibitors


References: 19 OctoberMedsafe. Dear Health Professional [letter] – The use of SSRI antidepressants in children and adolescents. 22 Marchwww.medsafe.govt.nz/hot/NZSSRIdoctorletter.pdf
Add to Reading List

Document Date: 2015-02-17 23:00:40

Open Document

File Size: 128,01 KB

Share Result on Facebook

City

Wellington / /

Company

Fairbank / /

Country

New Zealand / /

Facility

Grand Plimmer Tower / Heathcote / /

/

IndustryTerm

treatment of this disorder / /

MedicalCondition

bedwetting / Major Depressive Disorder / phobias / sudden cardiac death / bulimia nervosa / particularly treatment-resistant depression / premenstrual dysphoric disorder / childhood enuresis / restlessness / age groups worsening depression / depression / treatment-resistant depression / obsessive-compulsive disorder / /

MedicalTreatment

antidepressant therapy / /

Organization

Medicines Adverse Reactions Committee / Faculty of Child / Columbia University / UK Committee on Safety of Medicines / US Food and Drug Administration / American Medical Association / FDA / American Academy of Child and Adolescent Psychiatry / /

Person

Depressive Disorder / Henry D. Tricyclic / Stewart Jessamine / /

/

Position

Principal Technical Specialist / appropriate specialist / Eccles MP / Major / Adolescent Psychiatrist / /

Product

Venlafaxine / Fluoxetine / escitalopram / /

PublishedMedium

Journal of the American Medical Association / /

URL

www.medsafe.govt.nz/hot/NZSSRIdoctorletter.pdf / www.medsafe.govt.nz/profs/PUarticles/SSRI.htm / www.medsafe.govt.nz/Profs/RIss/unapp.htm / www.fda.gov/bbs/topics/news/2004/NEW01116.html / /

SocialTag